Pharmaco - Press Releases

Date	Title	Company
29-Jan-2021	RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib	RedHill Biopharma
29-Jan-2021	NEW RESEARCH PUBLISHED IN TOXICOLOGY IN VITRO PROVIDES INSIGHT INTO THE HEPATOTOXICITY OF DHODH INHIBITORS SUGGESTING ASLAN003 HAS THE POTENTIAL TO BE BEST-IN-CLASS	ASLAN Pharmaceuticals
29-Jan-2021	DNA ScriptsignsInnovation Development Contract with French Defence Innovation Agencyto EnableOn-demand DiagnosticsAgainst Emerging Biothreats	DNA Script
29-Jan-2021	PAION RECEIVES POSITIVE CHMP OPINION RECOMMENDING APPROVAL OF BYFAVO(R) (REMIMAZOLAM) IN PROCEDURAL SEDATION	PAION AG
29-Jan-2021	Solentim wins New Product Award at SLAS 2021	Sciad Newswire
29-Jan-2021	Covid Impact-19 on Oncology Drugs Market Therapeutics, Growth Analysis, Regional demand, Size and Forecast to 2030	Market Insights Reports
28-Jan-2021	Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research	Lonza Group AG
28-Jan-2021	Interplex Announces the Acquisition of OCP Group, Inc.	Interplex
28-Jan-2021	Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders	Sernova Corp.
28-Jan-2021	Toxys, Leiden University and Leiden University Medical Center Announce Licensing of ToxProfiler Technology for Animal-Free Chemical Safety Testing	B3C newswire
28-Jan-2021	ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery	ENPICOM BV
28-Jan-2021	Endogena completes $8 million financing and extends Series A round to advance its novel treatments for neurodegenerative diseases	Endogena Therapeutics Inc.
28-Jan-2021	MGB Biopharma - Successful End-of-Phase 2 Meeting with FDA for MGB-BP-3, a Potential New Gold Standard, First-Line Treatment for Clostridioides difficile Infection (CDI)	MGB Biopharma
28-Jan-2021	Pangaea Data raises further funding to accelerate deployment of its breakthrough AI with pharmaceutical companies and hospitals to improve patient outcomes	Pangaea Data
28-Jan-2021	Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA	Eckert & Ziegler Strahlen- und Medizintechnik AG
28-Jan-2021	Douglas’ sales almost stable at over €3 bn despite COVID-19 and due to strong e-commerce growth	Douglas GmbH
28-Jan-2021	Douglas GmbH: Douglas reduces its store network by around 500 stores; ongoing EBITDA contribution of around 120 million euros and net one-off cash charge of 94 million euros expected	Douglas GmbH
28-Jan-2021	MeVis Medical Solutions AG: MeVis publishes figures for fiscal year 2019/2020 and forecast for 2020/2021	MeVis Medical Solutions AG
28-Jan-2021	Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation	Evotec SE
28-Jan-2021	PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS	PAION AG